Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed attachment file name title grouped question UIN question first answered answering member label
tabling member	label

Search

1127421

registered interest
date	20/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bacterial Diseases
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 14 May (HL15384), what assessment they have made of the number of people, with or without resistant blood stream infections, who have Carbapenem resistant E. coli-like bacteria present in their bodies; and what (1) proposed, and (2) current, initiatives there are to control the transmission of such bacteria.
tabling member printed	Baroness Gardner of Parkes
uin	HL15832
answer	answer is ministerial correction date of answer 04/06/2019 answer text <p>The 2018 English surveillance programme for antimicrobial utilisation and resistance report contains information on carbapenem-resistant Escherichia coli (E. coli) causing bloodstream infections in England. In 2017 there were 18 cases. The number of people with other infections and carriage of E. coli resistant to carbapenems is harder to ascertain as surveillance is not as uniform.</p><p>Public Health England (PHE) publishes guidance on the prevention and control of carbapenemase-producing Enterobacteriaceae (including E. coli); guidance is available for both acute and non-acute settings, copies of the <em>Toolkit for managing carbapenemase-producing Enterobacteriaceae in non-acute and community settings</em> and <em>Acute trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae</em> are attached. PHE is supporting actions outlined in the United Kingdom’s Tackling Antimicrobial Resistance National Action Plan that aim to prevent and control the transmission of carbapenem-resistant bacteria, which includes reducing the number of specific drug-resistant infections in people by 10% by 2025; reducing UK antimicrobial use in humans by 15% by 2024; and adding carbapenem-resistant Gram-negative infections to the list of notifiable diseases in existing laboratory reporting systems.</p> answering member printed Baroness Blackwood of North Oxford attachment 1 file name Acute_trust_toolkit_for_the_early_detection.pdf title Acute trust toolkit 2 file name CPE-Non-AcuteToolkit_CORE.pdf title CPE Non Acute toolkit question first answered 04/06/2019 13:45:10 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3596 label Biography information for Baroness Gardner of Parkes

1127424

registered interest
date	20/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases: Medical Equipment
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the potential of schemes by pharmaceutical companies to develop recycling and recovery schemes for respiratory inhalers.
tabling member printed	Lord Hunt of Kings Heath
uin	HL15835
answer	answer is ministerial correction date of answer 04/06/2019 answer text <p>We are informed by NHS England that its joint Public Health England funded Sustainable Development Unit (SDU) has reviewed a scheme operated by GlaxoSmithKline that encourages return of inhalers for recycling. The scheme is very welcome but limited in scope, currently recovering around 1% of all inhalers.</p><p>All used inhalers can already be returned to all pharmacies to be disposed of by incineration with the medicines waste streams.</p><p>NHS England has invited industry suggestions to the national Low Carbon Inhalers Working Group established by the SDU, on ways to increase recovery for environmentally safe disposal and recycling.</p> answering member printed Baroness Blackwood of North Oxford question first answered 04/06/2019 13:46:45 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1127283

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to encourage fairer pricing by pharmaceutical companies for drugs supplied to the NHS.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	255651
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The 2019 Voluntary Scheme for Branded Medicines Pricing and Access, and the statutory scheme for branded medicines pricing, work together to control the cost of branded medicines to the National Health Service and ensure it stays within affordable limits.</p><p> </p><p>The 2019 Voluntary Scheme began on 1 January 2019 and will run for five years until the end of 2023. The Voluntary Scheme aims to provide stability and predictability for all parties in terms of the United Kingdom’s branded medicines expenditure and the medicines pricing and access environment for the period 2019 to 2023. It also aims to achieve a balance between patient access, affordability and supporting the development of innovative new medicines, including support for small companies.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/05/2019 14:30:06 answering member 4455 label Biography information for Seema Kennedy
tabling member	308 label Biography information for Mr Jim Cunningham

1127290

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood: Contamination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 13 May 2019 to Question 249855 on Blood: Contamination, whether any treatment is offered to donors whose blood donation tests are positive for infection.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	255657
answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>NHS Blood and Transplant’s Clinical Support Team provides support and advice for any donor whose blood donation tests positive for infection.</p><p>The donor will be asked to discuss the result with one of NHS Blood and Transplant’s Clinical Support Team clinical staff and, with the donor’s consent, NHS Blood and Transplant’s Clinical Support Team will arrange a referral to their general practitioner or a specialist, who will discuss the need for any treatment with the donor.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 24/05/2019 12:55:05 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	478 label Biography information for Lord Field of Birkenhead

1127292

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hormone Replacement Therapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the availability of (a) Evorel and (b) Femseven sequi patches.
tabling member constituency	Ellesmere Port and Neston
tabling member printed	Justin Madders
uin	255686
answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>The manufacturer of Evorel transdermal patches has confirmed that supplies of all presentations are currently available. However, they have stated that in some cases supplies are slightly lower than normal and therefore they are applying restrictions on orders as a precaution to ensure limited stock is maintained.</p><p>The Department is aware that the supplier of FemSeven Sequi patches is experiencing long term supply issues. As a result, they are expected to be out of stock until late 2019. We remain in regular contact with the company to resolve this as soon as possible.</p><p>Supplies of other hormone replacement therapy transdermal patches continue to remain available and patients affected have been advised to discuss these alternative treatment options with their clinician.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 24/05/2019 14:48:55 answering member 4455 label Biography information for Seema Kennedy
tabling member	4418 label Biography information for Justin Madders

1127293

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure that advance decisions on mental health treatment are respected and adhered to.
tabling member constituency	Bermondsey and Old Southwark
tabling member printed	Neil Coyle
uin	255683
answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>Last year Professor Sir Simon Wessely, president of the Royal Society of Medicine, submitted his independent review of the Mental Health Act. The review made 154 recommendations – including the establishment of new statutory advance choice documents, so that people’s wishes and preferences carry far more legal weight.</p><p>We have accepted this recommendation.</p><p>The Government is currently considering the detailed recommendations of the review and will respond in due course. We remain committed to reforming mental health law and will develop and bring forward legislation when Parliamentary time allows.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 255684 question first answered 24/05/2019 12:35:05 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4368 label Biography information for Neil Coyle

1127294

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure the adequate (a) monitoring and (b) use of advance decisions in mental health care.
tabling member constituency	Bermondsey and Old Southwark
tabling member printed	Neil Coyle
uin	255684
answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>Last year Professor Sir Simon Wessely, president of the Royal Society of Medicine, submitted his independent review of the Mental Health Act. The review made 154 recommendations – including the establishment of new statutory advance choice documents, so that people’s wishes and preferences carry far more legal weight.</p><p>We have accepted this recommendation.</p><p>The Government is currently considering the detailed recommendations of the review and will respond in due course. We remain committed to reforming mental health law and will develop and bring forward legislation when Parliamentary time allows.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 255683 question first answered 24/05/2019 12:35:05 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4368 label Biography information for Neil Coyle

1127316

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Crimes of Violence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 May 2019 to Question 252108 on Crimes of Violence, whether his Department has plans to make an estimate of the cost to the NHS of violent crime.
tabling member constituency	Lewisham, Deptford
tabling member printed	Vicky Foxcroft
uin	255688
answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>The Department currently has no plans to make an estimate of the cost to the National Health Service of violent crime.</p><p>However, the report ‘The economic and social costs of crime’<em>,</em> published by the Home Office, includes information on the costs associated with physical and emotional harms as a consequence of crime for health services. The report is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/the-economic-and-social-costs-of-crime" target="_blank">https://www.gov.uk/government/publications/the-economic-and-social-costs-of-crime</a></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 24/05/2019 12:36:24 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4491 label Biography information for Vicky Foxcroft

1127317

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the number of young people developing bowel cancer.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	255652
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>Obesity and poor diet are risk factors for bowel cancer in young people.</p><p>The second chapter of the world-leading childhood obesity plan was published in June 2018. This builds on the real progress made since the publication of chapter one in 2016, particularly in reformulation of the products our children eat and drink most. In chapter two we have set a bold ambition to halve childhood obesity by 2030 and significantly reduce the gap in obesity between children from the most and least deprived areas by 2030.</p><p>Many of the measures in both chapters of the plan will have an impact on tackling obesity across all age groups. These include the soft drinks industry levy, sugar reduction and wider calorie reformulation programme, restricting promotions and calorie labelling in restaurants which will improve our eating habits and reduce the amount of sugar we consume.</p><p>‘Childhood obesity: a plan for action, chapter 2’ is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/childhood-obesity-a-plan-for-action-chapter-2" target="_blank">www.gov.uk/government/publications/childhood-obesity-a-plan-for-action-chapter-2</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/05/2019 14:24:08 answering member 4455 label Biography information for Seema Kennedy
tabling member	308 label Biography information for Mr Jim Cunningham

1127319

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Self-harm and Suicide
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 May 2019 to Question 252092 on Self-Harm and Suicide, where data on (a) self-harm and (b) suicide among family members of victims of violence is held.
tabling member constituency	Lewisham, Deptford
tabling member printed	Vicky Foxcroft
uin	255689
answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>This data is not available. The fact that a person who self harms or takes their own life is a family member of a victim of violence is not routinely recorded by the National Health Service.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 24/05/2019 12:58:26 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4491 label Biography information for Vicky Foxcroft